PortfoliosLab logoPortfoliosLab logo

ProShares UltraShort Nasdaq Biotechnology (BIS) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BIS. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to BIS

BIS charges 0.95% annually. There are 97 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.


Best Risk-Adjusted Alternatives to BIS

BIS has a PortfoliosLab risk / return rank of 1. There are 281 ETFs in the Leveraged Equities category with higher risk-adjusted ranks, going as high as 98.


Top Performing BIS Alternatives (YTD)

BIS is at -24.85% YTD. There are 225 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 615.57%.


Lowest Volatility Alternatives to BIS

BIS has 40.71% 1-year volatility. There are 82 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.93%.


Lowest Drawdown Alternatives to BIS

BIS has a 1-year max drawdown of -59.49%. There are 170 ETFs in the Leveraged Equities category with shallower 1-year drawdowns, going as shallow as -1.72%.


Other ETFs from ProShares

The 10 most viewed ProShares ETFs shown here include TQQQ, QLD, BITO and span 10 categories. AUM among these funds goes as high as $33B.


Often Compared With BIS

Investors most often compare BIS with BIB, RSPN, IBBQ. These 20 comparison targets span 12 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
ProShares Ultra Nasdaq BiotechnologyLeveraged Equities
89
21.11%
78.22MApr 2010BIS vs BIB
Invesco S&P 500® Equal Weight Industrials ETFIndustrials Equities, S&P 500, Equal Weight
36
11.17%
1.09BJan 2006BIS vs RSPN
Invesco Nasdaq Biotechnology ETFHealth & Biotech Equities
91
13.32%
75.06MJun 2021BIS vs IBBQ
AdvisorShares Ranger Equity Bear ETFInverse Equities
5
-5.56%
56.68MJan 2011BIS vs HDGE
CapForce IBD 50 ETFMid Cap Growth Equities
18
6.26%
89.40MApr 2015BIS vs FFTY
State Street Health Care Select Sector SPDR ETFHealth & Biotech Equities
72
5.90%
42.10BDec 1998BIS vs XLV
Nasdaq, Inc.
40
-2.37%
BIS vs NDAQ
Invesco Dynamic Pharmaceuticals ETFHealth & Biotech Equities
95
16.81%
472.10MJun 2005BIS vs PJP
Global X DAX Germany ETFEurope Equities
20
2.45%
229.05MOct 2014BIS vs DAX
Leverage Shares 2X Long PYPL Daily ETFLeveraged Equities
5
-22.38%
22.51MApr 2025BIS vs PYPG
GraniteShares 2x Long VRT Daily ETFLeveraged Equities
30
49.92%
37.80MMar 2025BIS vs VRTL
Vanguard Information Technology ETFTechnology Equities
52
20.36%
169.20BMar 2004BIS vs VGT
Leverage Shares 2X Long XYZ Daily ETFLeveraged Equities
9
24.19%
3.02MApr 2025BIS vs XYZG
Leverage Shares 2X Long COST Daily ETFLeveraged Equities
12.60%
8.57MSep 2025BIS vs COTG
SPDR S&P Biotech ETFHealth & Biotech Equities
94
20.69%
9.90BFeb 2006BIS vs XBI
Direxion Daily GOOGL Bull 2X SharesLeveraged Equities
91
15.09%
940.22MSep 2022BIS vs GGLL
Direxion Daily Semiconductor Bull 3X ETFLeveraged Equities, Semiconductors
90
172.95%
19.56BMar 2010BIS vs SOXL
Leverage Shares 2X Long TSM Daily ETFLeveraged Equities
66
48.29%
31.37MJan 2025BIS vs TSMG
Direxion Daily MSCI South Korea Bull 3X SharesSouth Korea Equities, Leveraged Equities, Asia Pacific Equities
78
65.13%
1.38BApr 2013BIS vs KORU
Leverage Shares 2X Long ARM Daily ETFLeveraged Equities
29
190.00%
53.21MJan 2025BIS vs ARMG

Compare BIS with Any Fund or Stock

Compare BIS with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair BIS with funds that move differently

ProShares UltraShort Nasdaq Biotechnology alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BIS.

Explore BIS Diversifiers